Wilmington-based Predicate AI Labs Inc., a health care technology company developing predictive artificial intelligence to treat critical illness, has entered into an agreement with the Mayo Clinic, a top academic medical center.
According to a news release, the agreement will help Predicate advance the early detection of sepsis, a condition that occurs when the body has a life-threatening response to infection and attacks its own organs and tissues.
Predicate will be able to work with Mayo Clinic experts in predictive health care, “combining clinical expertise and real-world insight to help accelerate the development and validation of AI-driven tools for earlier detection and intervention,” the release stated…